Sinphar Pharmaceutical Co Ltd (1734):企業の財務・戦略的SWOT分析

◆英語タイトル:Sinphar Pharmaceutical Co Ltd (1734) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C12810
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sinphar Pharmaceutical Co Ltd (1734) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sinphar Pharmaceutical Co Ltd (Sinphar) is a healthcare company that carries out the development, manufacture and sale of pharmaceutical drugs, healthy foods and cosmetics. The company’s pharmaceutical product portfolio includes antifungal agents, anti-hypersensitive agents, cardiovascular agents, dermatologic agents, ophthalmic agents, skincare products, health supplements and others. It also has several products in pipeline addressing dementia, dry age-related macular degeneration, triple-negative breast cancer, pancreatic cancer, genital warts and others. Sinphar also offers contract manufacturing services to pharmaceutical companies for the development of new products. It has presence in China, Taiwan, Canada and other countries. Sinphar is headquartered in Tungshan, Yilan, Taiwan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Sinphar Pharmaceutical Co Ltd – Key Facts 5
Sinphar Pharmaceutical Co Ltd – Key Employees 6
Sinphar Pharmaceutical Co Ltd – Key Employee Biographies 7
Sinphar Pharmaceutical Co Ltd – Major Products and Services 8
Sinphar Pharmaceutical Co Ltd – History 9
Sinphar Pharmaceutical Co Ltd – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 11
Company Overview 11
Sinphar Pharmaceutical Co Ltd – Business Description 12
Sinphar Pharmaceutical Co Ltd – SWOT Analysis 13
SWOT Analysis – Overview 13
Sinphar Pharmaceutical Co Ltd – Strengths 13
Sinphar Pharmaceutical Co Ltd – Weaknesses 14
Sinphar Pharmaceutical Co Ltd – Opportunities 15
Sinphar Pharmaceutical Co Ltd – Threats 16
Sinphar Pharmaceutical Co Ltd – Key Competitors 17
Section 3 – Company Financial Ratios 18
Financial Ratios – Capital Market Ratios 18
Financial Ratios – Annual Ratios 19
Performance Chart 22
Financial Performance 22
Financial Ratios – Interim Ratios 23
Financial Ratios – Ratio Charts 24
Section 4 – Company’s Lifesciences Financial Deals and Alliances 25
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 26
Sinphar Pharmaceutical Co Ltd, Recent Deals Summary 27
Section 5 – Appendix 28
Methodology 28
Ratio Definitions 28
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Sinphar Pharmaceutical Co Ltd, Key Facts 5
Sinphar Pharmaceutical Co Ltd, Key Employees 6
Sinphar Pharmaceutical Co Ltd, Key Employee Biographies 7
Sinphar Pharmaceutical Co Ltd, Major Products and Services 8
Sinphar Pharmaceutical Co Ltd, History 9
Sinphar Pharmaceutical Co Ltd, Subsidiaries 10
Sinphar Pharmaceutical Co Ltd, Key Competitors 17
Sinphar Pharmaceutical Co Ltd, Ratios based on current share price 18
Sinphar Pharmaceutical Co Ltd, Annual Ratios 19
Sinphar Pharmaceutical Co Ltd, Annual Ratios (Cont...1) 20
Sinphar Pharmaceutical Co Ltd, Annual Ratios (Cont...2) 21
Sinphar Pharmaceutical Co Ltd, Interim Ratios 23
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 26
Sinphar Pharmaceutical Co Ltd, Recent Deals Summary 27
Currency Codes 28
Capital Market Ratios 28
Equity Ratios 29
Profitability Ratios 29
Cost Ratios 30
Liquidity Ratios 30
Leverage Ratios 31
Efficiency Ratios 31

List of Figures
Sinphar Pharmaceutical Co Ltd, Performance Chart (2013 - 2017) 22
Sinphar Pharmaceutical Co Ltd, Ratio Charts 24
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 26

★海外企業調査レポート[Sinphar Pharmaceutical Co Ltd (1734):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Waters Corporation (WAT)-医療機器分野:企業M&A・提携分析
    Summary Waters Corporation (Waters) is an analytical instrument manufacturing company. It carries out the design, production, commercialization and servicing of analytical technologies such as high performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), chromatograp …
  • Excelsior Medical Co., Ltd. (4104):企業のM&A・提携動向(医療機器分野)
    Summary Excelsior Medical Co., Ltd. (Excelsior Medical) formerly Enfield Medical Co., Ltd. is a medical equipment company that manufactures and markets products for intraluminal catheter care. Its products include SwabCap, SwabFlush, SwabKIT, ZR syringes, flush syringes, PharmAssist and syringe pump …
  • Soletanche Freyssinet Group:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Soletanche Freyssinet Group" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strict …
  • Anheuser-Busch Companies, LLC:企業の戦略的SWOT分析
    Anheuser-Busch Companies, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Axpo Holding AG:企業の戦略的SWOT分析
    Axpo Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Biomnis SELAS:医療機器:M&Aディール及び事業提携情報
    Summary Biomnis SELAS (Biomnis), a subsidiary of Eurofins Scientific SE, is a provider of medical laboratory testing services. The company offers laboratory tests in the areas of generics, biochemistry, immunology, cytogenics, assisted reproductive technology-embrology-sperm science, onco-haemotolog …
  • Black Box Corporation (BBOX):企業財務及び戦略的SWOT分析
    Summary Black Box Corporation (Black Box) ,formerly ACS Dataline LP is a technology service provider that offers comprehensive communications and infrastructure solutions. The company’s products include cabinets and racks, cables, datacom, digital signage, industrial, infrastructure hardware, tester …
  • Vietnam Oil and Gas Group(エネルギー分野):企業M&A動向
    Summary Vietnam Oil and Gas Group (Petrovietnam) is an oil and gas company. The company explores and develops oil and gas assets. Its activities include exploration and production of oil and natural gas, refining, processing of petrochemicals, and storage and transportation of petroleum products. Pe …
  • Eisai Co Ltd (4523):企業のM&A・提携動向(医療機器分野)
    Summary Eisai Co Ltd (Eisai) is one of the leading pharmaceutical companies in Japan. It undertakes the research, development, manufacture and marketing of pharmaceuticals, including over-the-counter (OTC) drugs and pharmaceutical production systems, besides chemicals, food ingredients and additives …
  • Corporate Office Properties Trust:企業の戦略・SWOT・財務分析
    SummaryCorporate Office Properties Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the co …
  • Femasys Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Femasys Inc. (Femasys) is a medical device company that offers medical device solutions for women’s healthcare. The company offers products for permanent contraception, infertility solutions and cancer diagnosis. Its products include fembloc permanent contraceptive system, femvue saline-air …
  • Amarin Corporation plc (formerly Ethical Holdings plc):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Amarin Corporation plc (formerl …
  • Abreos Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Abreos Biosciences Inc (Abreos Biosciences) is a biotechnology company that develops laboratory-based and point-of-care (POC) tests for precision dosing of biologic drugs. The company’s technology platform veritope, allow monitoring of monoclonal antibody drug levels in blood (novel or biosi …
  • Assurant, Inc.:企業の戦略・SWOT・財務情報
    Assurant, Inc. - Strategy, SWOT and Corporate Finance Report Summary Assurant, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • EnCana Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    EnCana Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary EnCana Corp (EnCana) is an oil and gas producer. The company explores, develops, produces and markets natural gas, oil and natural gas liquids (NGLs). Its major resource plays include Montney, Duvernay, …
  • Shree Renuka Sugars Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Shree Renuka Sugars Limited Mer …
  • Cenovus Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Cenovus Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Cenovus Energy Inc (Cenovus Energy) is an integrated energy company, which explores, develops, produces and markets crude oil, natural gas liquids (NGLs) and natural gas. Cenovus Energy produces n …
  • Sterling Energy plc (SEY):企業財務及び戦略的SWOT分析
    Summary Sterling Energy Plc (Sterling) is an oil and gas company that offers exploration and development services. The company acquires, develops and produces oil and natural gas assets. Its projects include Ntem, Ambilobe, Ampasindava and Odewayne. Sterling’s Ambilobe project is situated in the Amb …
  • Starbucks Corporation:企業概要・SWOT・財務分析
    Summary Canadean's "Starbucks Corporation : Retail - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, compan …
  • Vitrolife AB (VITR):企業のM&A・提携動向(医療分野)
    Summary Vitrolife AB (Vitrolife) is a biotechnology company that develops, produces and sells products and systems for assisted reproduction. The company provides products for the preparation, cultivation, preservation and support of human cells, tissues and organs. It supplies media and related dis …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆